COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

Thumbnail

‘The next wave of complications’: Asymptomatic COVID-19 patients face a prolonged stroke risk

The median time from a positive serological test result to acute ischemic stroke was nearly 55 days. 

Hospital allocates $517,000 toward vaccination bonuses, as health systems team to target hesitancy

Sixty top hospitals and healthcare institutions launched a nationwide campaign this week, targeting communities that have been slow to receive their first shot.

Football player cleared by cardiologist after missing time due to COVID-related myocarditis

Tommy Sweeney was the first NFL player to come down with myocarditis following a case of COVID-19, missing the rest of the 2020 season after his diagnosis in November.

Half of US adults have received one COVID-19 vaccine dose

Half of U.S. adults have received at least one dose of a COVID-19 vaccine, the Centers for Disease Control and Prevention disclosed. About one-third of adults are also fully vaccinated.

coronavirus COVID-19 vaccine vaccination

CDC recommends pause on Johnson & Johnson COVID vaccine

Following reports of a rare blood clot reaction, the Centers for Disease Control and Prevention recommended a pause in the use of the Johnson & Johnson vaccine out of “an abundance of caution.”

 

Thumbnail

Sedentary lifestyle doubles risk of death from COVID-19

An active lifestyle may be one of the best defenses against COVID-19, according to a new study that revealed inactivity contributes to higher rates of death among infected patients.

US recommends pause of Johnson & Johnson COVID-19 vaccine due to blood clot risk

The FDA and CDC announced the recommendation in a new joint statement. Nearly 7 million doses of the Johnson & Johnson vaccine have been administered in the United States so far. 

Johnson & Johnson COVID-19 vaccine being investigated for possible blood clot risk

The European Medicines Agency is investigating the issue with help from the FDA. At this stage, the group emphasized that it remains unclear if the Johnson & Johnson vaccine is associated with any specific blood clot risk.